PF
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
169.04
Exchange
XNYS - New York Stock Exchange, Inc
7.1 B
Last period Cash and equivalents ,USD
-45%
Cash and equivalents has decreased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Pfizer
Company Analysis
PFE valuation, rating, competitors, insights and company profile
Eyestock Rating
PFE financial analysis by Eyestock methodology
Valuation
PFE valuation using historical relative method
Statements
PFE Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PFE dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Pfizer`s Cash and equivalents for the period ended 2024-06-30 are 7.1 B USD
